<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The Fas ligand (FasL) pathway is one of the two major effector mechanisms of T-cell-mediated cell <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>FasL expression by extralymphatic tissues is thought to maintain a status of immunity </plain></SENT>
<SENT sid="2" pm="."><plain>Accordingly, it has been proposed that <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells express FasL as a mechanism of immunologic escape </plain></SENT>
<SENT sid="3" pm="."><plain>However, data regarding FasL expression in <z:mpath ids='MPATH_458'>normal</z:mpath> or neoplastic tissues remain controversial </plain></SENT>
<SENT sid="4" pm="."><plain>In the present study, we investigated the expression of FasL in <z:mpath ids='MPATH_458'>normal</z:mpath> peripheral blood B lymphocytes or malignant cells of the B-lymphocyte lineage to elucidate a possible immunologic counterattack mechanism </plain></SENT>
<SENT sid="5" pm="."><plain>FasL gene expression was analyzed by reverse transcriptase polymerase chain reaction in two non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NHL) entities: the highly aggressive Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) and indolent NHL <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> (CLL) </plain></SENT>
<SENT sid="6" pm="."><plain>FasL expression was found to be consistently negative in <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cell lines and purified samples from patients with CLL </plain></SENT>
<SENT sid="7" pm="."><plain>FasL is not constitutively expressed in <z:mpath ids='MPATH_458'>normal</z:mpath> peripheral blood or neoplastic B lymphocytes making the Fas counterattack, as described for <z:e sem="disease" ids="C0685938" disease_type="Neoplastic Process" abbrv="">gastrointestinal cancer</z:e>, unlikely as a mechanism of immunologic escape of <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells </plain></SENT>
</text></document>